Cutaneous vasculitis associated with rifampin therapy.
Immune complex-mediated vasculitis is a well-recognized form of idiosyncratic drug reaction. We report cutaneous vasculitis in association with therapy with rifampin (rifampicin). To our knowledge, this has not previously been documented. Rifampin is widely used, and such reactions are therefore important to note.
Iredale
J P
JP
Department of Respiratory Medicine, Rayne Laboratory, City Hospital, Edinburgh, Scotland.
Sankaran
R
R
Wathen
C G
CG
D000368:Aged; D004359:Drug Therapy, Combination; D006801:Humans; D007677:Kidney Function Tests; D008111:Liver Function Tests; D008297:Male; D012293:Rifampin / Q000009:adverse effects* / Q000627:therapeutic use; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy; D018366:Vasculitis, Leukocytoclastic, Cutaneous / Q000139:chemically induced*
D012293:Rifampin